Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| alpha 1-Antitrypsin Deficiency | 9 | 2025 | 69 | 4.200 |
Why?
|
| Genetic Therapy | 14 | 2025 | 802 | 2.970 |
Why?
|
| Dependovirus | 14 | 2025 | 721 | 2.910 |
Why?
|
| Genetic Vectors | 14 | 2025 | 889 | 2.640 |
Why?
|
| Gene Transfer Techniques | 7 | 2025 | 324 | 1.690 |
Why?
|
| alpha 1-Antitrypsin | 8 | 2025 | 94 | 1.630 |
Why?
|
| Gene Editing | 5 | 2025 | 324 | 1.060 |
Why?
|
| Transduction, Genetic | 4 | 2020 | 239 | 1.040 |
Why?
|
| Recombinant Proteins | 2 | 2018 | 704 | 0.860 |
Why?
|
| Primates | 1 | 2024 | 55 | 0.820 |
Why?
|
| Lung | 8 | 2023 | 964 | 0.680 |
Why?
|
| Animals | 28 | 2025 | 20962 | 0.600 |
Why?
|
| Camelids, New World | 3 | 2021 | 9 | 0.560 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2018 | 54 | 0.540 |
Why?
|
| Rare Diseases | 1 | 2018 | 44 | 0.540 |
Why?
|
| Mice | 19 | 2025 | 11003 | 0.540 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 21 | 0.510 |
Why?
|
| Retina | 1 | 2017 | 126 | 0.480 |
Why?
|
| Capsid Proteins | 3 | 2025 | 103 | 0.470 |
Why?
|
| Green Fluorescent Proteins | 1 | 2017 | 375 | 0.460 |
Why?
|
| Extremities | 1 | 2015 | 46 | 0.460 |
Why?
|
| Animals, Newborn | 2 | 2017 | 245 | 0.430 |
Why?
|
| Transgenes | 6 | 2024 | 188 | 0.420 |
Why?
|
| Muscle, Skeletal | 2 | 2024 | 747 | 0.420 |
Why?
|
| Myocardium | 1 | 2013 | 289 | 0.330 |
Why?
|
| Liver Diseases | 2 | 2025 | 160 | 0.320 |
Why?
|
| Lung Diseases | 2 | 2025 | 183 | 0.320 |
Why?
|
| Urinary Bladder | 1 | 2010 | 45 | 0.320 |
Why?
|
| Albendazole | 1 | 2009 | 12 | 0.300 |
Why?
|
| Disease Models, Animal | 6 | 2025 | 2238 | 0.300 |
Why?
|
| Liver | 4 | 2025 | 868 | 0.300 |
Why?
|
| Endovascular Procedures | 1 | 2015 | 607 | 0.290 |
Why?
|
| Anthelmintics | 1 | 2009 | 47 | 0.290 |
Why?
|
| Brain | 1 | 2017 | 1581 | 0.280 |
Why?
|
| Humans | 19 | 2025 | 64244 | 0.260 |
Why?
|
| Regeneration | 4 | 2013 | 101 | 0.250 |
Why?
|
| Capsid | 2 | 2025 | 97 | 0.250 |
Why?
|
| Veins | 2 | 2017 | 64 | 0.240 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2025 | 9 | 0.220 |
Why?
|
| Gene Expression | 3 | 2020 | 851 | 0.220 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2025 | 18 | 0.220 |
Why?
|
| Founder Effect | 1 | 2024 | 11 | 0.210 |
Why?
|
| INDEL Mutation | 1 | 2024 | 19 | 0.210 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2024 | 20 | 0.200 |
Why?
|
| Homeostasis | 2 | 2025 | 369 | 0.200 |
Why?
|
| Endopeptidases | 1 | 2024 | 68 | 0.200 |
Why?
|
| Blotting, Western | 1 | 2024 | 614 | 0.190 |
Why?
|
| Alleles | 1 | 2024 | 448 | 0.190 |
Why?
|
| MicroRNAs | 2 | 2023 | 697 | 0.180 |
Why?
|
| Hepatocytes | 1 | 2024 | 220 | 0.180 |
Why?
|
| Muscles | 2 | 2020 | 179 | 0.180 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 147 | 0.170 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2022 | 145 | 0.170 |
Why?
|
| Endothelial Cells | 1 | 2022 | 193 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 6 | 2025 | 3450 | 0.170 |
Why?
|
| Fibroblasts | 1 | 2022 | 404 | 0.160 |
Why?
|
| Mutation | 3 | 2025 | 2629 | 0.160 |
Why?
|
| Injections, Intramuscular | 2 | 2020 | 72 | 0.150 |
Why?
|
| Drug Overdose | 1 | 2021 | 122 | 0.150 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2023 | 508 | 0.140 |
Why?
|
| Pulmonary Emphysema | 1 | 2018 | 108 | 0.130 |
Why?
|
| Orbit | 1 | 2017 | 16 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2013 | 1365 | 0.130 |
Why?
|
| Injections, Intravenous | 1 | 2017 | 156 | 0.130 |
Why?
|
| Aging | 2 | 2013 | 754 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 458 | 0.120 |
Why?
|
| Terminal Repeat Sequences | 1 | 2015 | 13 | 0.110 |
Why?
|
| Gene Silencing | 2 | 2022 | 405 | 0.110 |
Why?
|
| Arteries | 1 | 2015 | 80 | 0.110 |
Why?
|
| Models, Animal | 1 | 2015 | 240 | 0.110 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 901 | 0.110 |
Why?
|
| Kidney | 2 | 2021 | 455 | 0.110 |
Why?
|
| Neutrophils | 1 | 2017 | 378 | 0.110 |
Why?
|
| Cell Proliferation | 4 | 2013 | 1001 | 0.110 |
Why?
|
| Biopsy | 2 | 2017 | 447 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2025 | 1297 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 462 | 0.100 |
Why?
|
| Horse Diseases | 2 | 2011 | 20 | 0.100 |
Why?
|
| Containment of Biohazards | 1 | 2012 | 4 | 0.100 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2176 | 0.090 |
Why?
|
| Extracellular Matrix | 2 | 2011 | 139 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 460 | 0.090 |
Why?
|
| DNA | 1 | 2017 | 844 | 0.090 |
Why?
|
| Stem Cells | 2 | 2013 | 262 | 0.090 |
Why?
|
| Myofibroblasts | 1 | 2011 | 16 | 0.090 |
Why?
|
| Virus Replication | 1 | 2012 | 323 | 0.080 |
Why?
|
| Euthanasia, Animal | 1 | 2010 | 1 | 0.080 |
Why?
|
| Blood Urea Nitrogen | 1 | 2010 | 9 | 0.080 |
Why?
|
| Urination Disorders | 1 | 2010 | 8 | 0.080 |
Why?
|
| Pyelonephritis | 1 | 2010 | 8 | 0.080 |
Why?
|
| Urea | 1 | 2010 | 40 | 0.080 |
Why?
|
| Ureter | 1 | 2010 | 37 | 0.080 |
Why?
|
| Male | 3 | 2024 | 30295 | 0.080 |
Why?
|
| Rats | 1 | 2013 | 2005 | 0.070 |
Why?
|
| Multipotent Stem Cells | 1 | 2008 | 13 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 783 | 0.070 |
Why?
|
| Housing, Animal | 1 | 2006 | 15 | 0.060 |
Why?
|
| Dust | 1 | 2006 | 41 | 0.060 |
Why?
|
| Air Pollution, Indoor | 1 | 2006 | 37 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2020 | 219 | 0.060 |
Why?
|
| Pneumonectomy | 3 | 2013 | 116 | 0.060 |
Why?
|
| Ferrets | 1 | 2025 | 12 | 0.060 |
Why?
|
| Environmental Monitoring | 1 | 2006 | 149 | 0.060 |
Why?
|
| Female | 6 | 2018 | 33351 | 0.050 |
Why?
|
| Cattle | 1 | 2025 | 316 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2011 | 1294 | 0.050 |
Why?
|
| Dipeptides | 1 | 2023 | 68 | 0.050 |
Why?
|
| DNA Repeat Expansion | 1 | 2023 | 58 | 0.050 |
Why?
|
| C9orf72 Protein | 1 | 2023 | 114 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2024 | 215 | 0.050 |
Why?
|
| Trachea | 1 | 2022 | 85 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 364 | 0.040 |
Why?
|
| Clonixin | 1 | 2021 | 1 | 0.040 |
Why?
|
| Plasma Exchange | 1 | 2021 | 24 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2024 | 685 | 0.040 |
Why?
|
| Oligonucleotides | 1 | 2022 | 226 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2020 | 73 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2020 | 39 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 205 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2020 | 196 | 0.040 |
Why?
|
| Infant | 1 | 2024 | 1664 | 0.040 |
Why?
|
| Horses | 2 | 2011 | 52 | 0.040 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 178 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2020 | 256 | 0.040 |
Why?
|
| Proteins | 1 | 2023 | 760 | 0.030 |
Why?
|
| Enzyme Assays | 1 | 2017 | 15 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 74 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2017 | 197 | 0.030 |
Why?
|
| Time Factors | 2 | 2017 | 3724 | 0.030 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2017 | 184 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2017 | 247 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2018 | 2140 | 0.020 |
Why?
|
| Gene Order | 1 | 2012 | 32 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2011 | 43 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 1431 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 205 | 0.020 |
Why?
|
| Collagen | 1 | 2011 | 124 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2011 | 134 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 297 | 0.020 |
Why?
|
| Actins | 1 | 2011 | 261 | 0.020 |
Why?
|
| Pancreatic Elastase | 1 | 2009 | 32 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 110 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 1332 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2011 | 401 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2008 | 93 | 0.020 |
Why?
|
| Transcriptome | 1 | 2011 | 396 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 1222 | 0.020 |
Why?
|
| Epidemiological Monitoring | 1 | 2006 | 31 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 2006 | 38 | 0.020 |
Why?
|
| Aerosols | 1 | 2006 | 47 | 0.020 |
Why?
|
| Air Pollutants, Occupational | 1 | 2006 | 74 | 0.020 |
Why?
|
| Seasons | 1 | 2006 | 138 | 0.020 |
Why?
|
| Apoptosis | 1 | 2011 | 1094 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 1551 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1621 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 5339 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2011 | 6726 | 0.010 |
Why?
|